The RDD 2018 program sessions include:
• Frontiers in Lung Biology
• Exploring the Targeting Offered by Inhalation and Molecular Design
• Exploring the Benefits of Smart Inhalers on Public Health
• Deposition Modelling for Pharmaceutical Aerosols – Dealing with Dynamic Change
• Optimizing Aerosol Delivery with Respiratory Support Devices
• Strategies for Regional Nasal Targeting
• Innovations in Pharmaceutical Engineering
• Expanding the Marketplace for Generic Inhalers via Improved Testing & Regulatory Guidance
Richard Dalby, one of the organizers of the meeting, said that delegates regularly express an appreciation for the effort that goes into creating programming of interest to OINDP specialists. “We usually go out of our way to identify people that are doing really relevant but different things from related areas that have direct applicability to development of pulmonary and nasal products,” he notes.
Dalby said that he is particularly interested to hear the plenary lecture by Fernando Martinez, Director of the University of Arizona Health Sciences Asthma and Airway Disease Research Center titled, “The Importance of Early Life Predictors of Airway Disease:New Strategies to Prevent Asthma and COPD.”
“The first session on Frontiers in Lung Biology will also be interesting because the talks cover more than just treatment of symptoms — there are some insights into cell repair, lung maintenance, use of stem cells, topics that I think would be revolutionary if they were to translate into new drugs,” Dalby says. “And there is a session on everybody’s favorite topic at the moment, connected devices.”
“Obviously,” he adds, “the regulatory session is always interesting because the race for the first generic in the United States is of course still ongoing, so hearing how people are approaching that and what steps are being taken and maybe getting a few insights into the FDA views from Rob Lionberger is interesting even though it’s a story that has gone on for many years.”
Dalby points out that all of the podium and poster presentations for the meeting are associated with peer reviewed papers published by RDD Online and made available to delegates either in a hard copy or via an online database.
The RDD 2018 program includes several award presentations, including the announcement of the winner of The Charles G. Thiel Award for outstanding research and discovery in respiratory drug delivery during the opening session and the presentation of The VCU RDD Peter R. Byron Graduate Student Award during the Posters on the Podium session. The winner of The VCU RDD Peter R. Byron Graduate Student Award, which covers the meeting expenses of the winner, will be chosen based on the quality of research and presentation. All graduate students who present posters at the meeting are in contention for the award.
In addition to podium sessions, this year’s meeting also features a session in which delegates can elect to attend 2 30-minute seminars offered by meeting sponsors. Options include presentations by 3M Drug Delivery Systems, Aptar Pharma, and Lonza.